Finance

Lists
532488:BOM
Divi's Laboratories Ltd
₹ ९,२२०.००
+१.९९%
(+१८०.०५) 1D
अक्टोबर १६, १५:५६:१५ GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532488...
Open
₹ ९,०१३.३५
High
₹ ९,२४७.५०
Low
₹ ८,९८५.००
Mkt. cap
२४.५४ खरब
Avg. vol.
३३.६९ हजार
Volume
१७.२२ हजार
Dividend
०.३३%
Quarterly dividend
₹ ७.५०
Ex-dividend date
२०२६ जुलाई २४
P/E ratio
८३.६७
52-wk high
₹ १०,०००.००
52-wk low
₹ ५,६४८.००
EPS
₹ ११०.२०
Shares outstanding
२६.५५ करोड
No. of employees
१२ हजार
Open
₹ ९,०१३.३५
High
₹ ९,२४७.५०
Low
₹ ८,९८५.००
Mkt. cap
२४.५४ खरब
Avg. vol.
३३.६९ हजार
Volume
१७.२२ हजार
Dividend
०.३३%
Quarterly dividend
₹ ७.५०
Ex-dividend date
२०२६ जुलाई २४
P/E ratio
८३.६७
52-wk high
₹ १०,०००.००
52-wk low
₹ ५,६४८.००
EPS
₹ ११०.२०
Shares outstanding
२६.५५ करोड
No. of employees
१२ हजार
News stories
From web sources and news partners
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees११.६ हजार
Founded१९९० अक्टोबर १२
Headquarters-
Sector-
Last report
२०२६ अगस्ट १
Fiscal period
Q1 2027
₹ ३३.९५ / ₹ २४.६८
+३७.५८%beat
Revenue / Est. (INR)
३०.८० अरब / २७.६१ अरब
+११.५६%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२७.१५ अरब
२६.०४ अरब
२८.३१ अरब
३०.८० अरब
Cost of goods sold
१०.७३ अरब
९.४५ अरब
१३.४९ अरब
९.८६ अरब
Cost of revenue
१०.७३ अरब
९.४५ अरब
१३.४९ अरब
९.८६ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.५४ अरब
३.६७ अरब
३.९९ अरब
४.०८ अरब
Operating expense
८.६७ अरब
८.८७ अरब
६.६८ अरब
९.६५ अरब
Total operating expenses
१९.४० अरब
१८.३२ अरब
२०.१७ अरब
१९.५१ अरब
Operating income
७.७५ अरब
७.७२ अरब
८.१४ अरब
११.२९ अरब
Other non operating income
८२.०० करोड
६९.०० करोड
-२.२३ अरब
६४.०० करोड
EBT including unusual items
९.१२ अरब
७.८० अरब
९.६३ अरब
११.८० अरब
EBT excluding unusual items
९.१२ अरब
८.५४ अरब
९.५९ अरब
११.८० अरब
Income tax expense
२.२३ अरब
१.९७ अरब
२.१२ अरब
२.७८ अरब
Effective tax rate
२४.४५%
२५.२६%
२२.०१%
२३.५६%
Other operating expenses
४.०० अरब
४.०२ अरब
१.४९ अरब
४.२४ अरब
Net income
६.८९ अरब
५.८३ अरब
७.५१ अरब
९.०२ अरब
Net profit margin
२५.३८%
२२.३९%
२६.५३%
२९.२९%
Earnings per share
२५.९७
२४.०७
२८.३१
३३.९५
Interest and investment income
-
-
२.८४ अरब
-
Interest expense
-८.०० करोड
-६.०० करोड
-६.०० करोड
-६.०० करोड
Net interest expenses
-८.०० करोड
-६.०० करोड
२.७८ अरब
-६.०० करोड
Depreciation and amortization charges
१.१३ अरब
१.१८ अरब
१.२० अरब
१.३३ अरब
EBITDA
८.८८ अरब
८.७२ अरब
९.२९ अरब
१२.४४ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू